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Background: Chronic diseases, such as chronic kidney disease (CKD), are growing in incidence and prevalence, in
part due to an aging population. Support provided through home care services may be useful in attaining a more
efficient and higher quality care for CKD patients.
Methods: A systematic review was performed to identify studies examining home care interventions among adult
CKD patients incorporating all outcomes. Studies examining home care services as an alternative to acute, post-acute
or hospice care and those for long-term maintenance in patients’ homes were included. Studies with only a home
training intervention and those without an applied research component were excluded.
Results: Seventeen studies (10 cohort, 4 non-comparative, 2 cross-sectional, 1 randomized) examined the support
provided by home care services in 15,058 CKD patients. Fourteen studies included peritoneal dialysis (PD), two
incorporated hemodialysis (HD) and one included both PD and HD patients in their treatment groups. Sixteen studies
focused on the dialysis phase of care in their study samples and one study included information from both the
dialysis and pre-dialysis phases of care. Study settings included nine single hospital/dialysis centers and three regional/
metropolitan areas and five were at the national level. Studies primarily focused on nurse assisted home care patients
and mostly examined PD related clinical outcomes. In PD studies with comparators, peritonitis risks and technique
survival rates were similar across home care assisted patients and comparators. The risk of mortality, however, was
higher for home care assisted PD patients. While most studies adjusted for age and comorbidities, information about
multidimensional prognostic indices that take into account physical, psychological, cognitive, functional and social
factors among CKD patients was not easily available.
Conclusions: Most studies focused on nurse assisted home care patients on dialysis. The majority were single site
studies incorporating small patient populations. There are gaps in the literature regarding the utility of providing home
care to CKD patients and the impact this has on healthcare resources.
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The world population is aging and the segment of global
population 60 years of age and over is increasing at the
fastest pace ever seen in history [1]. The population trends
are reflected in the demographic profiles of patients with
diseases such as chronic kidney disease (CKD) that are
common in the elderly. In Canada, over half of the patients
initiating renal replacement therapy (RRT) in 2009 were
65 years of age and older [2]. In Europe, RRT patients* Correspondence: sema.aydede@ubc.ca
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unless otherwise stated.65 years of age and older had the highest rate of increase
in prevalence over the 1992–2005 period [3].
CKD populations, especially elderly end-stage renal dis-
ease (ESRD) patients, are faced with multiple medical and
social challenges such as having to cope with several co-
morbidities, physical disability, cognitive impairment and
social isolation [4-11]. These medical and social challenges
are significant in characterizing the impaired quality of life
in CKD patients [12,13]. Quality of life deteriorates as the
severity of CKD increases [14]. Home care (HC) services
may help CKD patients in coping with these challenges,
maintaining their independence and fulfilling their prefer-
ences of receiving care at home [15,16].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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resent a unique opportunity to examine HC services that
are utilized to varying degrees by different patient groups
but are considered beneficial especially in chronic condi-
tions [17]. In the case of non-ESRD CKD, the utilization of
HC may vary based on patient’s age and comorbidities and,
in the case of ESRD, it may vary based on the severity of
illness and therapy type. HC services may help in support-
ing ESRD patients who have chosen conservative care. The
independent treatment modalities for ESRD (peritoneal
dialysis, PD, and home hemodialysis, HHD), emphasized
as viable alternatives to facility-based treatment modalities
over the last decade, are less costly to direct service pro-
viders, with equivalent or superior patient outcomes and
quality of life [18-21]. Patients with ESRD, who are on PD
or HHD, however, may utilize more HC services compared
to those who are on a facility-based hemodialysis (HD),
partially offsetting cost saving [22,23]. On the other hand,
the intensity of HC services received may reduce the
number of hospitalizations and subsequent health sys-
tem costs [24-26] regardless of the stage of CKD and
the type of therapy for ESRD.
In general, HC services provide support to patients and
help them with the daily management of their diseases in
their communities. However, a proper characterization
and a systematic evaluation of these services within a high
risk, resource intense group of patients such as those with
CKD have not been undertaken. This systematic review
(SR) provides a rigorous account of research evidence on
HC use among those with CKD.
Methods
Eligibility criteria
Studies about adult patients with any CKD severity level
and a HC intervention regarding services provided in
patients’ homes were eligible. Our SR was not restricted
to studies that incorporated a comparison group. Studies
with interventions related to the market place and work-
ing conditions of HC professionals or organizational un-
derpinnings of HC organizations were excluded.
In the case of RRT, assisted PD patients could get help
from a family member, a friend or a HC worker. In this
SR, studies that focused on assisted PD in general with-
out providing subgroup results for HC assisted PD pa-
tients [27-32] and those that examined home visits for
reasons other than direct HC provision [33-36] were ex-
cluded. Unlike assisted PD, HHD is rarely available in an
assisted format. One recent study that focused on the
feasibility of nocturnal assisted HHD did not provide
subgroup results for HC assisted HHD patients and,
therefore, was not included in our SR [37].
In the case of palliative care, support services for CKD
patients could be provided in their home or at a hospice.
This study focused on home-based end-of-life care.Studies that examined palliative care without providing
information about the specific services patients received
in their community and those that did not separately re-
port on subgroups of patients who received home-based
support services [38-42] were excluded from our SR.
The primary outcomes included hospitalizations, admis-
sions to institutional settings, length of stay on independ-
ent dialysis modalities for ESRD patients, and outcomes
specific to treatment type. As secondary outcomes, mor-
tality, medication management, patient satisfaction, care-
giver satisfaction, physical and psychological well-being,
health status and quality of life were considered. Studies
were not excluded based on outcomes studied.
In general, all types of studies including experimental
and observational studies were included. The studies
that did not contain an empirical component and those
with only training/educational and referral/recommen-
dations types of interventions were excluded.
Given the diversity of HC services and resource consid-
erations, we concentrated on studies published in English.
To balance this limitation, a comprehensive literature
search was undertaken. The date range was 1990 (i.e., the
early stages of profound changes in healthcare systems
that started with shifts away from acute care settings to-
wards home and community care [43]) to present.
Definitions
CKD was conceptualized as consisting of five stages fol-
lowing the Kidney Disease Outcomes Quality Initiative’s
definition accepted during the Kidney Disease: Improving
Global Outcomes (KDIGO) conference [44]. The defin-
ition accepted during the KDIGO conference suggests that
CKD could also be classified by treatment type: kidney
transplant recipient, CKD independent of dialysis and
CKD on dialysis. These classifications guided the develop-
ment phase of our SR.
The Federal/Provincial/Territorial Working Group on
Home Care’s definition, as reported by Health Canada,
emphasizes the manner with which HC helps patients:
“An array of services which enables clients, incapacitated
in whole or part, to live at home, often with the affect of
preventing, delaying or substituting for long-term or acute
care alternatives” [45]. The Canadian Home Care Associa-
tion’s definition focuses on the breadth of services covered:
“an array of services, provided in the home and commu-
nity setting, that encompasses health promotion and teach-
ing, curative intervention, end-of-life care, rehabilitation,
support and maintenance, social adaptation and inte-
gration and support for the family caregiver” [46]. Initially,
HC conceptualization for this SR was guided by these
definitions. These conceptualizations were further refined
during the course of this study as we attempted to
standardize terminology for our SR based on HC services
covered in the included studies.
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Studies were identified through electronic databases, web sites,
hand searches and consultations with experts in the
field. Electronic databases included MEDLINE, EMBASE,
CINAHL, PsycINFO, EconLit, Cochrane CENTRAL, Cochrane
Methodology Register, Cochrane Database of Systematic
Reviews, Centre for Reviews and Dissemination (DARE,
HTA and NHS EED), ACP Journal Club and Web of
Science (final search for MEDLINE is incorporated in the
Appendix; final searches for other databases are available
from the corresponding author). The web sites included
World Health Organization, Health Canada, Canadian
Homecare Association, Canadian Health Research Collec-
tion and the health departments of Canadian provinces and
territories. The electronic database and web site searches,
conducted by a University of British Columbia librarian,
were completed on May 24, 2012. Hand searches, com-
pleted on September 20, 2013, were coupled with consulta-
tions with experts in the field.Study selection
We followed a layered approach in study selection. An ini-
tial elimination of irrelevant studies was carried out by
study assistants independently based on title and abstract
reviews using a pre-tested selection form. An author (SKA)
checked the initial selection and reviewed the complete
texts of potentially relevant studies. The remaining manu-
scripts were reviewed in full by two additional authors in-
dependently (AL and PK). Disagreements were resolved
after discussions among authors. Each selected study was
summarized using a pre-tested data extraction form and
was evaluated using the Agency for Healthcare Research
and Quality risk of bias and confounding form developed
for observational studies [47].Analysis
Due to the heterogeneity of patient populations consid-
ered, interventions examined and health outcomes re-
ported in the studies included in our SR, a meta-analysis
was not possible. We performed a narrative summary of
studies focusing mainly on key outcomes of importance
to the CKD community.Results
Study selection
A total of 17 studies were identified for inclusion in the
SR. The searches of electronic databases provided a total
of 4354 citations (Figure 1) with 185 additional citations
identified through hand-searches and author consulta-
tions. After adjustments for duplicates and title and ab-
stract screening, a total of 521 full text articles were
assessed and 17 were eligible for inclusion.Study characteristics and patient populations
Of the 17 studies included in this study (overview of study
characteristics in Table 1 and detail on patient popula-
tions, HC interventions and outcomes in Table 2), 14
focused on the impact HC has on PD patients. Ten of
the PD studies were cohort studies [48-57], three were
non-comparative [58-60] and one used cross sectional
study design [61]. Five national level PD cohort studies
[48,51,52,55,56] used information from the French Lan-
guage Peritoneal Dialysis Registry (RDPLF). Two of these
RDPLF studies [51,52] used the same time period but ap-
plied different exclusion criteria based on the focus of
the studies. Two PD cohort studies [53,54] relied on data
from regional dialysis units. The remaining three PD co-
hort studies [49,50,57] and all of the non-comparative and
cross sectional PD studies [58-61] used data from a single
hospital/dialysis unit. Of the 14 PD studies, 6 were from
France [48,50-52,55,56], 3 from Canada [53,54,58], 2 from
the United States of America (USA) [60,61] and one each
from China [57], Taiwan [49] and Brazil [59].
Of the 17 studies included in this study, 2 studies exam-
ined the impact HC has on HD patients. One of these
studies was a randomized trial [62] conducted in an Iranian
hospital and the second one was a non-comparative study
that used information from citywide dialysis units in the
USA [63].
In contrast to the general trend of studies included in
this SR where the focus was exclusively on the dialysis
phase of care for patients, one study [64] included in-
formation from both the dialysis and pre-dialysis phases
of care for PD and HD patients. This study explored
the impact HC has on patients in one hospital in the
United Kingdom.
The studies included in this SR examined HC in a total
of 15,058 patients (Table 2). Patients on PD treatment
(with a total of 14,954 patients) constituted the dialysis
population that was most frequently studied. While most
studies focused on general dialysis populations, two PD
studies [58,60] and one HD study [63] examined HC in
special dialysis populations that had severe disability, ter-
minal illness or complex comorbid conditions.
Of the 17 studies included in this review, 3 focused on
elderly patients [48,49,53] with average age of the study
samples ranging from 73 years [49] to 82 years [48]. In
the remaining studies with pertinent information, aver-
age age ranged from 55 years [56,61] to 69 years [63].
The PD studies with comparators and pertinent infor-
mation revealed that HC assisted PD patients had a
higher average age ranging from 71 years [57] to 83 years
[48] when compared to the overall age of study samples.
Home care intervention
HC interventions primarily focused on the assistance pro-























4354 titles identified via
electronic and web site  
185 additional titles identified
through other sources 





assessed for eligibility 
504 full-text articles excluded:
• 26 no chronic kidney disease 
patients 
• 7 had subjects younger than
19 years of age 
• 245 no original data
• 166 no home care patients
• 41no separate analysis for
home care patients 
• 19 home visit for reasons
other than providing home care 
17 studies included in
the systematic review 
Figure 1 Chronic kidney disease & home care systematic review PRISMA flow diagram.
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and most of the HC assisted PD studies [48,50-53,55,
56,58,60] focused on assistance dialysis patients received
from a nurse. Two of the remaining studies [61,64] con-
sidered the effects of HC teams and the rest focused onassistance received from either a home-assistant where a
background in healthcare was not necessary [49,57], a
nurse assistant [59] or a nurse or a healthcare aid [54].
There are several factors, such as the severity of illness,
the scope of HC provision and the requirements of dialysis
Table 1 Overview of study characteristics
Study Type of study Setting, data source & data period Country
Peritoneal dialysis
Brunier et al. [58] Non-Comparative (Case Series) • Hospital Canada
• Sunnybrook Health Science Centre (November 1993 - May 1995)
Castrale et al. [48] Retrospective Cohort • National France
• French Peritoneal Dialysis Registry Data (January 2000 - December 2007)
Franco et al. [59] Non-Comparative (Case Series) • Clinic Brazil
• GAMEN Renal Clinic (January 2003- July 2009)
Hsieh et al. [49] Prospective Cohort • Hospital Taiwan
• Chang Gung Memorial (January 2000 - December 2009)
Lobbedez et al. [50] Retrospective Cohort • Hospital France
• Academic Hospital of Basse-Normandie (1 January 1998–31 December 2003)
Lobbedez et al. [51] Retrospective Cohort • National France
• French Peritoneal Dialysis Registry Data (1 January 2002 – 1 June 2011)
Lobbedez et al. [52] Retrospective Cohort • National France
• French Peritoneal Dialysis Registry Data (1 January 2002 – 1 June 2011)
Oliver et al. [53] Prospective Cohort • Regional Dialysis Center Canada
• Sunnybrook Health Science Centre (1 January 2004–25 May 2006)
Oliver et al. [54] Prospective Cohort • 4 Regional Dialysis Centers Canada
• Sunnybrook Health Science Centre (HSC), Halton Healthcare, London
HSC, Manitoba Renal Program (January 2004 - January 2009)
Ponferrada et al. [61] Cross Sectional (Survey) • Dialysis Unit USA
• Dialysis Clinic Inc (Data period not reported)
Verger et al. [55] Retrospective Cohort • National France
• French Peritoneal Dialysis Registry Data (1 January 1995–1 January 2006)
Verger et al. [56] Retrospective Cohort • National France
• French Peritoneal Dialysis Registry Data (1 January 2000 – 1 January 2005)
Wadhwa et al. [60] Non-Comparative (Case Series) • Hospital USA
• Division of Nephrology and Hypertension - State University of New
York (January 1989 - December 1992)
Xu et al. [57] Prospective Cohort • Hospital China
• Peking University First Hospital (July 2002 - April 2010)
Hemodialysis
Agraharkar et al. [63] Non-Comparative (Case Series) • Citywide USA
• Dialysis centers in the greater Houston area (1995–1998)
Babamohammadi et al. [62] Randomized controlled trial • Hospital Iran
• Fatemyeh Hospital (Data period not reported)
Pre-dialysis & dialysis
Wilde et al. [64] Cross Sectional (Survey) • Hospital UK
• Leicester General Hospital (Data period not reported)
Aydede et al. BMC Nephrology 2014, 15:118 Page 5 of 18
http://www.biomedcentral.com/1471-2369/15/118technique used, that will influence the characteristics of
a HC intervention. While patients on continuous cyc-
ling PD (CCPD) will mostly require two visits per day,
those on continuous ambulatory PD (CAPD) may re-
quire one to four visits based on the severity of their
disability [56,58]. The time that a HC worker spends ata CAPD patient’s home is dependent on the CAPD system
used. PD exchange help for a patient on an ultraviolet
non-disconnect CAPD system will usually require less
time (about 10–15 minutes) compared to the time (about
30–45 minutes) needed for a patient on a double-bag
disconnect CAPD system [55].
Table 2 Patient population, intervention type and major findings of studies
Study Number of patients Mean age Type of home care intervention Major findings
Peritoneal dialysis
Brunier et al. [58] • 18 HC assisted PDα • 61 • HCβ (Nurse) assisted PD: Publicly funded program
where nurses visit homes for PD exchanges and
clinical and social support
Peritonitis Rate:
• One episode of peritonitis per 33.8
patients-months (excluding 1 low
white blood and 1 AIDS patient); if
included, one episode of peritonitis
per 20.1 patients-months
• CAPDγ required 1–4 visits / day based on severity
of disability
Hospitalization Rate:
• One hospital admission per 15.3
patient-months (excluding 5 palliative
care patients)
• CCPDδ required 2 visits / day
Costs:
• Reporting on 3 years of experience
• Annual costs were $27,263 for home
CAPD, $29,763 for home CCPD and
$29,915 for HDε
Castrale et al. [48] • 1232 HC assisted PD • 83 (HC assisted PD) • HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
Peritonitis Rate:
• Compared to self care PD, HC
(nurse) assisted PD had similar risks
of peritonitis rates (Bivariate results)
• 87 Family assisted PD • 81 (Family assisted PD)
• Study end point allowed for at least 2 years of
follow-up for patients who are on PD continuously
(Frequency of visits not reported)
Patient Survival:
• Compared to self care PD, HC
(nurse) assisted PD was associated
with a higher risk of mortality
(RHζ = 2.35)
• 294 Self care PD • 80 (Self care PD)
Technique Survival:
* Elderly
• Compared to self care PD, HC (nurse)
assisted PD had similar risks of
technique failure (=transfer to HD)
Franco et al. [59] • 30 HC assisted PD • 72 (Median) • HC (Nurse Assistant) assisted PD: Home visits by
nurse assistants for assisted PD
Peritonitis Rate:
• One episode of peritonitis per 37
patient-months• Study end point allowed for at least 16 months
of follow-up for patients who are on PD
continuously (Frequency of visits not reported) Patient Survival:
• Patient survival was 60% at 12
months, 23% at 24 month, 3% at
48 months



















Table 2 Patient population, intervention type and major findings of studies (Continued)
Hsieh et al. [49] • 32 HC assisted PD • 76 (HC assisted PD) • HC (Home Assistant) assisted PD: Home assistants
(a background in healthcare was not required)
paid by the family assisted with PD.
Peritonitis Rate:
• Peritonitis rates of 1 episode per
24 (HC-home assistant-assisted PD),
37 (family assisted PD) and 39 (self PD)
patient months were not significantly
different
• 44 Family assisted PD • 74 (Family assisted PD)
• HC assisted PD patients followed for 93 to
1832 days (Frequency of visits not reported)
• Probability of a 12 month peritonitis-free
periods of 62.5% (HC-home
assistant-assisted PD), 75.0% (family
assisted PD) and 80.8% (self PD) were
not significantly different
• 26 Self care PD • 69 (Self care PD)
Patient Survival:
* Elderly
• Peritonitis-related deaths of 13.8% (HC-home
assistant-assisted PD), 8.0% (family assisted PD)
and 8.0% (self PD) were not significantly different
Technique Survival:
• Following peritonitis, technique failures
of 34.5% (HC-home assistant-assisted PD),
16.0% (family assisted PD) and 16.0%
(self PD) were not significantly different
Lobbedez et al. [50] • 36 HC assisted PD • 74 (HC assisted PD) • HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
PD Eligibility/Utilization/Uptake:
• HC (nurse) assisted PD enables increased
use of PD in incident dialysis patients
• 61 Self care PD • 52 (Self care PD)
• HC assisted PD patients followed for 0.5 to
51 months (Frequency of visits not reported)
Peritonitis Rate:
• HC (nurse) assisted PD patients: Actuarial
survival free of peritonitis was 72% at
6 months, 50% at 12 months
• 36 Satellite HD • 47 (Satellite HD)
Hospitalization Rate:
• 106 In-center HD • 67 (In-center HD)
• HC (nurse) assisted PD patients:
• Actuarial survival free of hospitalization
46% at 6 months, 21% at 12 months
• Hospitalization rate was 0.4 admissions/
patient/month
Technique Survival:
• HC (nurse) assisted PD patients: Technique
survival 85% at 6 months, 58% at 12 months
Charlson Comorbidity Index:
• Charlson Comorbidity Index higher for HC
(nurse) assisted PD (7.0) when compared to
self care PD (4.3) and similar when



















Table 2 Patient population, intervention type and major findings of studies (Continued)
Lobbedez et al. [51] • 4230 HC assisted PD • 79 (Median, HC assisted PD) • HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
Patient Survival:
• Compared to self care PD, HC (nurse) assisted
PD was associated with a higher risk of mortality
(cs-RHη = 4.52)
• 1056 Family PD • 74 (Median, Family assisted
PD) • Study end point allowed for at least 5 months
of follow-up for patients who are on PD
continuously (Frequency of visits not reported)
• Compared to self care PD + family assisted PD,
HC (nurse) assisted PD was associated with a
higher risk of mortality (cs-RH = 2.18)
• 4515 Self care PD
• 56 (Median, Self care PD)
• Interquartile range of PD duration 7.78 to
29.70 months
Technique Survival:
• Compared to self care PD, HC (nurse) assisted
PD was associated with a lower risk of technique
failure (=transfer to HD, cs-RH = 0.84, sd-RHθ = 0.72)
• Compared to self care PD+ family assisted PD, HC (nurse)
assisted PD was associated with a lower risk of technique
failure (=transfer to HD, cs-RH = 0.85, sd-RH = 0.72)
Renal Transplantation:
• Compared to self care PD, HC (nurse) assisted PD
was associated with a lower risk of renal
transplantation (cs-RH = 0.04)
• Compared to self care PD + family assisted PD, HC
(nurse) assisted PD was associated with a lower risk
of renal transplantation (cs-RH = 0.16)
Renal Recovery:
• Compared to self care PD, HC (nurse) assisted PD
was associated with a similar risk of renal recovery
(Bivariate results)
• Compared to self care PD+ family assisted PD, HC (nurse)
assisted PD was associated with a similar risk of renal recovery
Lobbedez et al. [52] • 3689 HC assisted PD • 71 (Median, Planned PD
Start)
• HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
Peritonitis Rate:
• Compared to self care PD, HC (nurse) assisted PD was
associated with a lower risk of peritonitis (sd-RH = 0.81)
• 902 Family PD
• 69 (Median, Sub-optimal PD
Start)
• Study end point allowed for at least 5 months of
follow-up for patients who are on PD continuously
(Frequency of visits not reported) Patient Survival:
• Compared to self care PD, HC (nurse) assisted PD was
associated with a higher risk of mortality (sd-RH = 6.30)
• 3891 Self care PD
• Interquartile range of PD duration 8.08 to
29.99 months
Technique Survival:
• Compared to self care PD, HC (nurse) assisted PD was
associated with a lower risk of technique failure (=transfer
to HD, sd-RH = 0.67)
*Additional exclusions compared
o Lobbedez et al., 2012 to focus
on sub-optimal PD starts
Renal Transplantation:
• Compared to self care PD, HC (nurse) assisted PD was
associated with a lower risk of renal transplantation



















Table 2 Patient population, intervention type and major findings of studies (Continued)
Oliver et al. [53] • 22 HC assisted PD • 76 (Median, HC assisted PD) • HC (Nurse) assisted PD: Publicly funded program
where nurses visit homes for PD exchanges and
clinical and social support
PD Eligibility/Utilization/Uptake:
• More elderly patients were considered eligible for PD
(ORι = 2.6) if they lived in a HC support region than if
they did not
• 4 Self care PD • 76 (Median, Other
Modalities)
• First year of dialysis, HC assisted PD patients
received, on average, 5.8 visits / week
Hospitalization Rate & Days:
• Hospitalization rate was not significantly different
between HC (nurse) assisted PD (1.4 per patient-year)
and other modalities (1.0 per patient-year)
• 16 In-center HD
*Elderly
• HC assisted PD patients offered 2 visits / day
7 days a week
• Hospital days were not significantly different between
HC (nurse) assisted PD (23.5 per patient-year) and other
modalities (13.1 per patient-year)
• Mean follow-up for HC assisted PD patients
were 413 days
Patient Survival:
• Mortality was not significantly different between HC
(nurse) assisted PD (0.12 per patient-year) and
other modalities (0.18 per patient-year)
Technique Survival:
• Modality changes were not significantly different
between HC (nurse) assisted PD (0.04 per patient-year)
and other modalities (0.19 per patient-year)
Oliver et al. [54] • 56 HC assisted PD • 66 (Overall) • HC (Nurse or Healthcare Aid) assisted PD:
Publicly funded program where nurses or
healthcare aids visit homes for assisted PD
PD Eligibility/Utilization/Uptake:
• Even when HC (nurse or healthcare aid) assisted PD is
available, family support remains to be an important
driver of PD utilization.
• 8 Family and HC assisted PD
• Maximum 2 nurse or healthcare aid visits/day
• Among patients with barriers to PD who live in areas
with HC assisted PD availability, PD utilization was higher
(39%) among those who had family support compared
to those without family support (23%)
• 26 Family assisted PD
• Mean (median) follow-up for PD patients were
521 (376) days
• 1 Friend assisted PD
• 56 Self care PD
Ponferrada et al. [61] • 36 HC assisted PD • 55 • HC (Team) assisted PD: Home visits by home
care team (nurse, dietician & social worker) for
assisted PD and patient assessments
Critical Elements of Home Visits:
• Dialysis programs should retain the option of making
home visits to home dialysis patients
• Reporting on evaluation over a 18-month period
• To evaluate internal policy and identify critical
elements of a home visit
• Study recommendations: One routine visit for
new patients and additional non-routine visits
only if there are significant problems



















Table 2 Patient population, intervention type and major findings of studies (Continued)
Verger et al. [55] • 5284 HC assisted PD • 66 (Overall) • HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
PD Eligibility/Utilization/Uptake:
• Provides a description of the PD population• 822 Family assisted PD
• Nurse time at patient’s home for: a) non-disconnect
CAPD ultraviolet system between 10–15 minutes,
and b) double-bag disconnect CAPD system
between 30–45 minutes (Frequency of visits
not reported)
• Over the decade studied, 45% of all incident PD patients
received HC (nurse) assisted PD and 87% of incident PD
patients over 90 years of age received HC (nurse) assisted PD
• 8285 Self care PD
Charlson Comorbidity Index:
• Among prevalent PD patients, Charlson comorbidity index,
on average, was 7.6 for HC (nurse) assisted PD, 6.6 for family
assisted PD and 4.8 for self care PD
• 352 Other / Undefined PD
Verger et al. [56] • 232 HC assisted PD • 73 (HC assisted PD) • HC (Nurse) assisted PD: Publicly funded home
visits by private sector nurses for assisted PD
Peritonitis Rate:
• The probability of being peritonitis free at 24 months
better for family assisted PD (76.7%) compared to HC
(nurse) assisted PD (41.2%) when nurse visits from dialysis
centers are not considered
• 127 Family assisted PD • 65 (Family assisted PD)
• Study end point allowed for at least 13 months
of follow-up for patients who are on PD continuously
• The probability of being peritonitis free at 24 months
similar between family assisted PD (57.7%) and HC (nurse)
assisted PD (60.7%) when nurse visits from dialysis centers
are considered
• 1265 Self care PD • 51 (Self care PD)
• 1–2 nurse visits / day
• For HC (nurse) assisted PD, the probability of being
peritonitis free better for those affiliated with dialysis
centers with nurse visits
*Automated PD patients only
• For family assisted PD, the probability of being peritonitis
free similar across centers with and without nurse visits
Wadhwa et al. [60] • 21 HC assisted PD • 62 • HC (Nurse) assisted PD: Home visits by nurses for
assisted PD and clinical support
Peritonitis Rate:
• One episode of peritonitis per 13 patient-months
• Mean number of nursing hours per day was 13
(Frequency of visits not reported) Hospitalization Rate & Days:
• One hospital admission per 6 patient-months
• Mean hospitalization days of 9 per admission
Xu et al. [57] • 36 HC assisted PD • 71 (HC assisted PD) • HC (Home Assistant) assisted PD: Home assistants
(a healthcare background was not required) paid
by the family assisted with PD
Peritonitis Rate:
• First episode of peritonitis was not significantly different
between HC (home assistant) assisted PD and family
assisted PD
• 86 Family assisted PD • 66 (Family assisted PD)
• PD patients followed for 1 to 88 months
(Frequency of visits not reported)
Patient Survival:
• Compared to family assisted PD, HC (home assistant) assisted
PD was associated with higher risk of mortality (HR = 2.14)
• 191 Self care PD • 55 (Self care PD)
Technique Survival:
• Technique survival was not significantly different between
HC (home assistant) assisted PD (69.8 months) and family



















Table 2 Patient population, intervention type and major findings of studies (Continued)
Hemodialysis
Agraharkar et al. [63] • 28 HC assisted HD • 69 • HC (Nurse) Assisted HD: Home visit by registered
nurse for dialysis and clinical support
Hospital Days:
• Mean hospitalization days of 9.43+/−1.83
• Nephrologists also made home visits Costs:
• HD patients followed for 2 to 71 weeks • Weekly ongoing costs of HC(nurse) assisted HD were
$1200, in-center HD with ambulance transportation were
$2640 and in-hospital dialysis were $5241• Frequency of visits determined by the nephrologist
upon patient’s discharge from the hospital
Babamohammadi
et al. [62]
• 19 HC assisted HD • 56 (HC assisted HD) • HC (Nurse) Assisted HD: Visits every week before
HD schedule for clinical support and retraining
19 Clinical Outcomes:
• 15 out of the 19 items studied improved for home care
group (weight gain, nausea, vomiting, headache, bone
pain, weakness and fatigue, and itching decreased
and general condition and levels of BUN, creatinine,
potassium and phosphorus of the blood improved
significantly. Changes in the mean values of blood
pressure, pulse, temperature, sodium and calcium
and hematocrit were not significant)
• 18 HD without HC • 58 (HD without HC)
• Mean follow-up for HC assisted HD patients were
27.1 months
• 4 visits / month
Pre-dialysis & Dialysis
Wilde et al. [64] • 57 HC assisted PD or HD • Not described • HC (Team): Home care team (3 nurses & 1 renal
care assistant) visits during pre-dialysis and dialysis
phase of care for PD and HD patients
Satisfaction with Home Care:
• Overall satisfaction with home care program: a) pre-dialysis
phase of care− 76% very satisfied, 20% partly satisfied and b)
dialysis phase of care− 80% very satisfied, 20% partly satisfied• Visits until transplantation, switch to hospital-based
dialysis or death (Frequency of visits not reported)
αPD: Peritoneal Dialysis.
βHC: Home Care.
γCAPD: Continuous Ambulatory Peritoneal Dialysis.
δCCPD: Continuous Cycling Peritoneal Dialysis.
εHD: Hemodialysis.
*Elderly: Identifies studies focusing on patients at least 65 years of age and older.
ζRH: Relative Hazard.
ηcs-HR: Cause-Specific RH.




















Table 3 Risk of bias and confounding
Risk of bias and confounding
Q1: Do the inclusion/exclusion criteria remain identical across the comparison groups (the individuals) of the study?
Peritoneal
Dialysis
Yes Castrale [48], Franco [59], Hsieh [49], Lobbedez [51,52], Verger [55,56], Xu [57]
Partially Brunier [58], Lobbedez [50], Oliver [53,54], Ponferrada [61], Wadhwa [60]




Q2: Does the strategy for recruiting participants into the study remain identical across groups (individuals)?
Peritoneal
Dialysis
Yes Brunier [58], Castrale [48], Franco [59], Hsieh [49], Lobbedez [50-52], Oliver [53,54], Ponferrada [61], Verger [55,56],
Wadhwa [60], Xu [57]




Q3: Is the selection of the comparison group appropriate, after taking into account feasibility and ethical considerations?
Peritoneal
Dialysis
Yes Castrale [48], Hsieh [49], Lobbedez [50-52], Oliver [53,54], Verger [55,56], Xu [57]
Not Applicable Brunier [58], Franco [59], Ponferrada [61], Wadhwa [60]
Hemodialysis Yes Babamohammadi [62]
Not Applicable Agraharkar [63]
Pre-dialysis &
Dialysis
Not Applicable Wilde [64]
Q4: Does the study account for important variations in the execution of the study?
Peritoneal
Dialysis
Yes Castrale [48], Franco [59], Lobbedez [51,52], Oliver [53,54], Ponferrada [61], Verger [56]
Partially Brunier [58], Hsieh [49], Lobbedez [50], Wadhwa [60], Xu [57]
Not Applicable Verger [55]





Q5: Were valid and reliable measures, implemented consistently across all study participants used to assess inclusion/exclusion criteria,
intervention/exposure outcomes, participant benefits and harms, and potential confounders?
Peritoneal
Dialysis
Yes Brunier [58], Castrale [48], Franco [59], Hsieh [49], Lobbedez [50-52], Oliver [53,54], Ponferrada [61], Verger [55,56],
Wadhwa [60], Xu [57]




Q6: Was the length of follow-up identical across study groups or remedied through analysis?
Peritoneal
Dialysis
Yes Castrale [48], Lobbedez [51,52], Xu [57]
No Hsieh [49], Lobbedez [50], Oliver [53], Verger [56]
Not Applicable Brunier [58], Franco [59], Oliver [54], Ponferrada [61], Verger [55], Wadhwa [60]
Hemodialysis Yes Babamohammadi [62]
Not Applicable Agraharkar [63]
Pre-dialysis &
Dialysis
Not Applicable Wilde [64]





No Brunier [58], Oliver [53], Wadhwa [60]
Not Applicable Oliver [54], Ponferrada [61], Verger [55]
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Table 3 Risk of bias and confounding (Continued)
Cannot
Determine
Castrale [48], Franco [59], Hsieh [49], Lobbedez [50], Verger [56], Xu [57]
Hemodialysis Cannot
Determine




Q8: Are all important primary outcomes accounted for in the results?
Peritoneal
Dialysis
Yes Brunier [58], Castrale [48], Franco [59], Hsieh [49], Lobbedez [50-52], Oliver [53,54], Ponferrada [61], Verger [55,56],
Wadhwa [60], Xu [57]





Q9: Are results believable taking study limitations into consideration?
Peritoneal
Dialysis
Yes Brunier [58], Castrale [48], Franco [59], Hsieh [49], Lobbedez [50-52], Oliver [53,54], Ponferrada [61], Verger [55,56],
Wadhwa [60], Xu [57]








Yes Castrale [48], Lobbedez [51,52], Oliver [53], Verger [56], Xu [57]
No Hsieh [49], Lobbedez [50], Oliver [54], Verger [55]
Not Applicable Brunier [58], Franco [59], Ponferrada [61], Wadhwa [60]
Hemodialysis Yes Babamohammadi [62]
Not Applicable Agraharkar [63]
Pre-dialysis &
Dialysis
Not Applicable Wilde [64]
Q11: Were important confounding variables taken into account in the design and/or analysis (e.g., through matching, stratification,
interaction terms, multivariate analysis, or other statistical adjustment such as instrumental variables)?
Peritoneal
Dialysis
Partially Castrale [48], Franco [59], Hsieh [49], Lobbedez [51,52], Oliver [53], Verger [56], Xu [57]
No Brunier [58], Lobbedez [50], Oliver [54], Ponferrada [61], Verger [55], Wadhwa [60]
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in Canada [53,54] were offered 14 visits per week for
help with their PD exchanges and for the provision of
clinical and social support. These patients received, on
average, 5.8 visits per week during the first year of their
dialysis [53]. In a USA program, a routine visit to a new
PD patient was carried out to ensure proper installation
of the cycler for an effective dialysis and non-routine
visits were made only on an as-needed basis [61]. In this
program, a visit took approximately four hours. Another
USA program focused on ESRD patients with multiple
medical and social problems [60]. In this program, a visit
to help patients with their PD exchanges and to provide
clinical and social support took, on average, 13 hours. Ina HD study from Iran, the HC intervention was designed
to conduct one visit per week before the HD schedule
for clinical support and retraining [62].
Outcomes
Peritoneal dialysis
While most of the PD studies focused on outcomes re-
lated to PD treatment (Table 2), a few provided insights
into how the availability of assisted PD offers a choice to
patients who are unable to perform their RRT independ-
ently. A description of the PD population in France [55],
where healthcare system supports nurse assisted PD, re-
vealed that 45% of all PD patients and 87% of those over
90 years of age were assisted by a nurse. Studies have
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the eligibility for PD among elderly patients [53] and im-
proved the uptake of PD in general [50]. One study [54]
emphasized the importance of the availability of family
assistance for PD utilization even in regions where HC
assisted PD is available.
In PD studies with comparators, outcomes such as
peritonitis rate and technique and patient survival con-
stituted the main areas of focus. In general PD popula-
tions, studies using information from RDPLF concluded
that technique failure/transfer to HD was lower among
HC (nurse) assisted PD patients when compared to self
care PD patients only [51,52] and to self care PD and
family assisted PD patients as a group [51]. Another
study in general PD populations [57], where home-
assistants who were not required to have a background
in healthcare helped PD patients, found that the prob-
ability of technique survival times were similar between
HC assisted PD and family assisted PD patients. Studies
that focused on elderly concluded that the probability of
technique failure was similar between HC (nurse)
assisted PD patients and comparators including patients
on self care PD [48] and traditional modalities (i.e., self
care PD and in-center HD) [53]. The probability of tech-
nique failure following an episode of peritonitis was also
similar between home-assistant assisted PD and self care
PD and family assisted PD patients [49].
Peritonitis rate was another outcome examined in PD
studies with comparators. In almost all of these studies,
HC assisted PD patients and the comparators (including
family assisted PD among general PD populations [57],
self care PD among elderly [48] and self care PD and
family assisted PD among elderly [49]) had similar prob-
abilities of being peritonitis free. In one study [52], HC
assisted PD patients had lower peritonitis rates when
compared to self care PD. In another study [56], HC
assisted PD patients had higher peritonitis rates when
compared to family assisted PD patients. However, the
difference in peritonitis rates observed in the latter study
disappeared when the effects of regular nurse visits from
dialysis centers to the HC assisted PD patients were
taken into consideration.
Most of the PD studies with comparators that examined
patient survival found a higher probability of mortality
among HC assisted PD patients. This result continued to
hold across different comparators including self care PD
among general PD populations [51,52], self care PD and
family assisted PD among general PD populations [51],
family assisted PD among general PD populations [57],
and self care PD among elderly PD populations [48]. Two
studies about elderly populations were exceptions. In the
first study, the risk of mortality did not differ between pa-
tients receiving nurse assisted PD and those on traditional
modalities [53]. In the second study, peritonitis-relatedmortality was similar among home-assistant assisted PD
and self care PD and family assisted PD patients [49].
The PD studies without comparators focused on vary-
ing outcomes such as identifying critical elements of a
home visit [61] and exploring costs of RRTs [58]. The
studies that considered PD patients with severe disability
reported peritonitis rates that ranged from 1 episode per
13.0 patient-months [60] to 20.1 patient-months [58]
and hospitalization rates that ranged from 1 admission
per 6.0 patient-months [60] to15.3 patient-months [58].
A recent study from Brazil [59] found 1 peritonitis epi-
sode per 37.0 patient-months and 60% patient survival
at one year among a general PD population.
Hemodialysis
The HD study with a comparator [62] concluded that
patients in HC group had improved on 15 of the 19 out-
comes considered (including decreases in nausea, vomit-
ing, headache, bone pain, weakness and fatigue and
itching and improvements in general condition and the
levels of creatinine, potassium and phosphorus of the
blood). The HD study without a comparator [63] fo-
cused on patients diagnosed with terminal illness and
found that, on average, patients were hospitalized for
9.43 days.
Pre-dialysis and dialysis
Based on survey results, more than three-fourths of PD
and HD patients were very satisfied with the pre-dialysis
and dialysis phase of their care after the implementation
of HC program [64]. The HC team consisting of three
nurses and one renal care assistant provided continuous
social support to patients. The HC team also collected
information about patients’ life goals and provided infor-
mation to them about their dialysis modalities.
Risk of bias and confounding
While most studies had low risk of bias in many do-
mains (Table 3), apart from two studies [51,52] that used
imputations techniques for missing information, loss to
follow-up was rarely discussed. Some of the studies
[48,49,51-53,56,57] have taken into consideration con-
founding variables such as age and Charlson Comorbidity
Index (CCI). The CCI summarizes the impact comorbid
conditions have on survival by assigning higher weights to
more severe coexisting conditions such as metastatic car-
cinoma and lower weights to less severe ones such as de-
mentia [65-67]. While CCI is one of the most widely used
risk adjustment techniques in observational studies, the
characteristics of CKD populations may require multidi-
mensional prognostic indices that take into account phys-
ical, psychological, cognitive, functional and social factors
[68]. One of the studies included in this SR reported on
the physical performance of patients using Karnofsky
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bidity scores [59]. Apart from the descriptive information
incorporated in the latter study, there were no studies that
incorporated multidimensional indices as another con-
founding variable in their analysis.
Discussion
Our SR revealed that most of the studies that examined
the impact of HC services among CKD patients focused
on dialysis patients, in general, and PD patients, in par-
ticular. Among RRTs, assisted PD provides an option for
ESRD patients who prefer home-based dialysis therapies
but have barriers to self care including physical disability
and cognitive impairment. HC assisted PD becomes es-
pecially valuable for ESRD patients with additional bar-
riers to self care such as social isolation. The current
increases in the prevalence of elderly ESRD patients
partly explain the greater emphasis placed on assisted
PD in the CKD HC literature.
The HC assisted PD studies incorporated in this re-
view mostly underscored clinically relevant outcomes for
PD such as peritonitis rate and technique and patient
survival. The findings show that technique survival and
peritonitis rates for HC assisted PD patients were at
least similar to or better than those for self care PD and
family assisted PD patients. The studies that found bet-
ter technique survival [51,52] and peritonitis rates [52]
for HC (nurse) assisted PD patients relied on national
level French registry using the same time period. The
availability of HC assisted PD may reduce the likelihood
of adverse events by improving patient’s psycho-social
status and supporting them in adhering to the basic
principles of PD including peritonitis prevention. Fur-
ther studies are needed to examine if favorable outcomes
continue to hold for HC assisted PD patients in different
regions across the world.
Most PD studies found a higher probability of mortality
among HC assisted PD patients when compared to self
care PD or family assisted PD. These studies indicated that
patients in their HC assisted PD group were older and
had higher levels of comorbidities as captured by the CCI.
The higher probability of mortality among HC assisted
PD patients persisted in studies that controlled for age
and CCI differences across groups. The authors mostly at-
tributed this finding to data insufficiencies in capturing
disabilities among PD populations. Apart from one study
[59] that described comorbidity and physical performance
in their study population, there were no studies that incor-
porated multidimensional indices that take into account
physical, psychological, cognitive, functional and social
factors as another confounding variable in their analysis.
The studies included in this SR provided limited infor-
mation about the characteristics of the HC interven-
tions. In general, technical requirements imposed on HCintervention based on the dialysis type used are well
known among the CKD community. Additional studies
that consider HC interventions with varying scope and
frequency and duration of visits in different CKD popu-
lations will provide helpful information to the CKD
community, especially for those who are considering HC
programs for their own clinic/practice.
One of the gaps in the literature that was identified by
our SR is related to the provision of HC services among
non-ESRD CKD populations. Apart from one study [64]
that incorporated information about patient experiences
with the implementation of a HC program that affected
both the dialysis and pre-dialysis phases of their care,
there were no studies that explored the impact HC has
on non-ESRD CKD populations. It is well known that
CKD is often accompanied by several comorbid condi-
tions, is common among older people and its prevalence
increases with age. As emphasized by the World Kidney
Day 2014 Steering Committee [69], these characteristics
of CKD coupled with increased life expectancy world-
wide call for further explorations into ways of optimizing
health for elderly populations. The impact different HC
services might have in improving health among non-
ESRD CKD patients is one such area that deserves fur-
ther explorations.
The lack of studies on the impact home palliative care
has on patients with CKD is another gap in the literature
that was identified by our SR. The quality of life consid-
erations for CKD patients who are at the advance stages
of their disease require focus on several issues including
the management of their physical and psycho-social
symptoms and the development of an advanced care
plan that sets the goals for their care [70-74]. Studies
that examine the impact home palliative care has on pa-
tients with CKD who are at the advance stages of their
disease will help further advance the integration of pal-
liative and renal care.
Our SR identified other gaps in the literature. There
were no studies about HC provision among kidney
transplant patients. Studies related to HC provision
among HD patients were limited to small samples.
The HC interventions incorporated in the CKD litera-
ture were mostly limited to nursing care for ESRD pa-
tients. There were no studies about the provision of
home support for activities of daily living or respite care
for caregivers of CKD patients. While HC may become
more important as CKD severity increases and, in the
case of ESRD, it may be most useful for patients on
home-based dialysis modalities or for those who choose
conservative care, further studies are needed to quantify
these differing levels of HC use and its impact.
One of the strengths of our study is the comprehen-
sive SR conducted on a topic where there were, to the
best of our knowledge, no previous SR undertaken. The
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with hand searches and expert consultations resulted in
the identification of several gaps in the literature.
Our study has several limitations. One of the limita-
tions of our study is arising from the subject matter it-
self. HC, as encompassing a diverse set of medical and
psycho-social services, is one of the health services re-
search areas that are constantly evolving with limited
standardization in terminology. Our study which focused
on the intersection of home care with CKD faced add-
itional challenges given the changes in CKD definition
itself in the past years that is continuing through today
[75]. We made an attempt to balance this fundamental
limitation by conducting comprehensive database searches,
extensive hand searches and expert consultations. Second
limitation of our study is the layered approached followed
in study selection. Third limitation is the focus on stud-
ies published in English. Given the diversity of HC ser-
vices, resource and time considerations were crucial
factors in our decision to follow a layered study selection
approach and to focus on studies published in English. As
indicated above, we made an attempt to balance these lim-
itations by conducting comprehensive database searches,
extensive hand searches and expert consultations. Another
limitation is our inability to conduct a meta-analysis for
our study. The diversity of patient populations, HC inter-
ventions and outcomes studied made it impossible to con-
duct a meta-analysis.Conclusions
In this era of aging world population and medical and
technical advances, chronic diseases, such as CKD, are
growing in incidence and prevalence. HC may be useful
in providing a more efficient and higher quality care for
CKD patients. However, a synthesis of evidence on the
effects of HC among CKD patients has not been under-
taken. Our SR, which aimed at filling this void, revealed
that extant studies almost exclusively focused on nurse
assisted HC patients examining mostly PD related clin-
ical outcomes. Our study concluded that there are sev-
eral gaps in the literature. Specifically, there were no
studies in areas such as home support for activities of
daily living, palliative care at home or respite care for
caregivers of CKD patients, in general, or for ESRD pa-
tients, in particular.Appendix
MEDLINE Search Strategy:
1. exp kidney diseases/
2. exp renal replacement therapy/
3. ((kidney or renal) adj2 (disease* or failure or
damage or insufficiency)).mp.4. ((kidney or renal) adj2 (transplant*5 or dysfunction
or therap*)).mp.
5. (dialysis or dialyses or haemodialysis).mp.
6. Kidney, Artificial/
7. (kidney* adj artificial).mp.
8. or/1-7 (540012)
9. exp home care services/
10. (domiciliary adj3 (care or service$ or nurs$)).mp.
11. “home nurs$3”.mp.
12. ((home or care) adj3 (nonprofession$ or non-
professional$)).mp.
13. (homemaker adj3 service$).mp.
14. (home adj3 service$).mp.
15. “home care”.mp.
16. (home adj3 (renal or dialys$3 or hemodialy$3 or
peritoneal)).mp.
17. ((parenteral or nutrition or feeding) adj home).mp.
18. (“hospital at home” or “hospital in the home” or
“in-home care”).mp.
19. “home health care”.mp.
20. (Home adj3 (rehabilitation or occupational or
physical or physiotherap$ or social worker$ or
speech)).mp.
21. Day Care/
22. (palliative adj5 home).mp.
23. ((caregiver$ or care-giver$ or carer$) adj3 “respite
care”).mp.
24. ((long-term or long term) adj3 (home care or
home-care)).mp.
25. activities of daily living.sh. and home.tw.
26. (personal care adj3 home).mp.
27. (self-care adj3 home).mp.
28. (day adj3 care).mp.
29. self care.sh. and home.tw.
30. or/9-29
31. 8 and 30
32. limit 31 to (english language and yr=“1990
-Current”)
33. limit 32 to “all child (0 to 18 years)”
34. 32 not 33.
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